Abstract
Myoinositol is an insulin sensitizing agent. It is used in the management of polycystic ovary syndrome.
It ameliorates the metabolit profle. It improves quality and quantity of oocytes in women with PSOS.
Hirsutism and acne are reduced by myoinositol. It reduces risk of NTD and gestational diabetes.